Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.110
-0.050 (-4.31%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Lineage Cell Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $3 | Buy | Maintains | $3 | +170.27% | Aug 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $9 | Buy | Maintains | $9 | +710.81% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 → $9 | Buy | Reiterates | $7 → $9 | +710.81% | Aug 7, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 15, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $3 → $4 | Buy | Maintains | $3 → $4 | +260.36% | Mar 25, 2026 |